The Nifty extended its losing streak with a sixth consecutive decline, slipping below the 25,000 support level amid broad-based selling, especially in pharma and IT stocks. Analysts warn of further downside if 24,500 breaks, though a recovery remains possible. Stock recommendations include Ashok Leyland, Dr Agarwal’s Health Care, Dixon, and Anant Raj.
Sebi board meeting: PMS rules overhaul, FPI commodity trades among key decisions to watch out
Sebi’s upcoming board meeting aims to discuss significant changes to portfolio management services and settlement regulations. Proposed revisions could allow discretionary portfolio managers to make